key: cord-0846851-5wzj7iwu
authors: Klein, Robyn; Soung, Allison; Sissoko, Cheick; Nordvig, Anna; Canoll, Peter; Mariani, Madeline; Jiang, Xiaoping; Bricker, Traci; Goldman, James; Rosoklija, Gorazd; Arango, Victoria; Underwood, Mark; Mann, J. John; Boon, Adrianus; Dowrk, Andrew; Boldrini, Maura
title: COVID-19 induces neuroinflammation and loss of hippocampal neurogenesis
date: 2021-10-29
journal: Res Sq
DOI: 10.21203/rs.3.rs-1031824/v1
sha: b6c6e0d6c13726eacf4b9cce93c4595c3d09dad1
doc_id: 846851
cord_uid: 5wzj7iwu

Infection with the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is associated with onset of neurological and psychiatric symptoms during and after the acute phase of illness(1–4). Acute SARS-CoV-2 disease (COVID-19) presents with deficits of memory, attention, movement coordination, and mood. The mechanisms of these central nervous system symptoms remain largely unknown. In an established hamster model of intranasal infection with SARS-CoV-2(5), and patients deceased from COVID-19, we report a lack of viral neuroinvasion despite aberrant BBB permeability, microglial activation, and brain expression of interleukin (IL)-1β and IL-6, especially within the hippocampus and the inferior olivary nucleus of the medulla, when compared with non-COVID control hamsters and humans who died from other infections, cardiovascular disease, uremia or trauma. In the hippocampus dentate gyrus of both COVID-19 hamsters and humans, fewer cells expressed doublecortin, a marker of neuroblasts and immature neurons. Despite absence of viral neurotropism, we find SARS-CoV-2-induced inflammation, and hypoxia in humans, affect brain regions essential for fine motor function, learning, memory, and emotional responses, and result in loss of adult hippocampal neurogenesis. Neuroinflammation could affect cognition and behaviour via disruption of brain vasculature integrity, neurotransmission, and neurogenesis, acute effects that may persist in COVID-19 survivors with long-COVID symptoms.

humans ( Table 1 ) who died of other infections (39%), cardiovascular disease (46%), uremia (8%) and trauma (8%).

The Golden Syrian hamster is naturally susceptible to SARS-CoV-2 infection. Intranasal inoculation results in mild-to-moderate disease with labored breathing, ru ed fur, weight loss, and hunched posture 5. To assess acute neuroin ammation following SARS-CoV-2 infection, 5-6-week-old male hamsters were infected intranasally with 2 x 10 5 plaque forming units (PFU) of a fully infectious SARS-CoV-2 isolate (strain 2019-nCov/USA-WA1/20202). Whole heads of uninfected and infected hamsters were collected throughout the acute infectious period and at one week after viral clearance, which occurs in the lungs at 5-7 days post-infection (dpi) 18 . High levels of SARS-CoV-2 RNA was detected within the hamster ethmothurbinates at 2-4 days post infection (dpi), and completely cleared by 8 dpi (Fig. 1a,b) . As previously reported 19 , viral RNA was detected only within K18 + sustentacular cells of the olfactory neuroepithelium (ONE) (Fig. 1c) , which might impact olfactory sensory neuron (OSN) function via loss of calcium signaling 20 . SARS-CoV-2-infected sustentacular cells exhibited decreased expression of K18 + compared with uninfected ONE (Supplementary Video 1) and were found sloughed off into the nasal cavities of infected hamsters (Supplementary Video 2). Consistent with lack of OSN infection and neuroinvasion via the olfactory route, no viral RNA was detectable in the acute and recovered hamster olfactory bulb (OB), cortex, hippocampus, and medulla oblongata at any timepoint post-infection ( Supplementary Fig. 1a ).

Consistently with our hamster ndings, we previously assessed 41 COVID-19 subjects who underwent autopsy and neuropathological exam, which we reported to show no viral RNA in brain tissue, as detected by RNAscope or RT-PCR 14 (Supplementary Fig. 1b ).

Disruption of the BBB may occur during infection with respiratory viruses 21 . To evaluate effects of SARS-CoV-2 on BBB integrity in the hamster model, we assessed brain levels of extravasated serum IgG via immunohistochemistry. At 3-4 dpi there was a signi cant increase in IgG in the CNS parenchyma compared to naïve animals, which gradually decreased by 14 dpi (Fig. 1d ). Further assessment of IgG extravasation revealed regional differences in BBB permeability following infection. While all regions examined, which include OB, cortex, hippocampus, and medulla oblongata, showed some degree of BBB disruption, the hippocampus suffered the most signi cant changes compare to naïve hamsters (Fig. 1e) . The medulla oblongata exhibited little BBB disruption at early timepoints, but signi cant detection of IgG at 5 dpi (Fig. 1e) . Similar persistent alterations in IgG immunoreactivity were observed in the OB and cortex, albeit to a lesser degree when compared to the hippocampus ( Supplementary Fig. 2a) .

We next examined BBB permeability in human COVID-19 brain tissue samples via detection of brinogen, a blood coagulation protein whose CNS deposition is implicated in a wide range of neurological disease and injuries associated with BBB disruption 22 . In a subset of COVID-19 decedents (n=7) compared with age and sex-matched controls (Table 1 ) deceased from other infections (n=3) or cardiovascular disease (n=2), we observed increased brinogen in the hippocampus (Fig. 1f) , and a smaller non-signi cant increase in medulla (Fig. 1f ) and OB ( Supplementary Fig. 2b ). Together, these data suggest that SARS-CoV-2 infection may lead to region-speci c alterations in human BBB integrity.

SARS-CoV-2 infection is associated with aberrant expression of brain cytokines Loss of BBB integrity may permit CNS entrance of cytokines or immune cells, which, in turn, may activate glial cells 23 . Given the observed increased BBB permeability in SARS-CoV-2 infected hamsters and humans, we examined microglia activation and cytokine expression by glia and neurons.

Medulla oblongata from SARS-CoV-2-infected hamsters showed activated microglia within the inferior olivary nuclei (ION), displaying larger cell bodies and thicker processes than those detected in uninfected tissues, and increased levels of ionized calcium-binding adapter molecule 1 (IBA1) at 4 dpi, which remained elevated at 14 dpi (Fig. 2a) . In vertebrates, ION are found in the medulla underneath the superior olivary nucleus, and coordinate signals from the spinal cord to the cerebellum, regulating motor coordination and learning via integration of glutamatergic synaptic inputs 24 . In the medulla ION, IBA1 + activated microglia of SARS-CoV-2-infected hamsters exhibited increased expression of IL-1β at 2-5 dpi, which returned to baseline by 8 dpi, compared to uninfected hamsters ( Fig.  2b) . Unfortunately, there are no commercially available antibodies to detect IL-6 in hamster tissues.

Analysis of COVID-19 patients revealed increased microglial activation, and IL-1β expression within the ION compared with control patient tissues ( Fig. 2c-f ). Elevated expression of IL-6 was detected in ION neurons, suggesting neuronal cytokine production (Fig. 2g) , as previously reported 27 .

Hippocampal SARS-CoV-2-hamster tissue revealed a gradual increase in IBA1 + activated microglia versus uninfected hamsters, peaking at 5 dpi (Fig. 3a) , and IL-1β levels increased at 2 dpi, peaking at 5 dpi before gradually decreasing to naïve levels by 14 dpi (Fig. 3b ).

Hippocampal tissue from COVID-19 patients exhibited subtle changes in IBA1 + expression and microglial production of IL-1β compared with control patients (Fig. 3c-g) . Similar to the medulla ION, we also observed neurons to be the main source of IL-6 in COVID-19 patient hippocampi compared to controls (Fig. 3i) .

OB of both SARS-CoV-2-infected hamsters (2-5 dpi) and humans exhibited elevated expression of IL-1β within IBA1 + microglia compared with uninfected control tissues ( Supplementary Fig. 4a ,c). In hamster somatosensory cortex, co-localization of IL-1β within IBA1 + microglia was not signi cantly elevated ( Supplementary Fig. 4b ). In hamsters, OB and somatosensory cortex showed similar microglial activation, but this was not observed in OB of COVID-19 patients versus controls ( Supplementary Fig. 3a-d) . However, OB from COVID-19 patients exhibited elevated neuronal expression of IL-6 compared with controls ( Supplementary Fig. 4d ). IL-6 has been shown to have both pro-and anti-in ammatory roles 28 ; further investigation of its role in COVID-19 is needed. Altogether, these data suggest neurons are important players in controlling neuroin ammation in humans affected by SARS-CoV-2.

We determined whether astrocytes contribute to neuroin ammation in the CNS of infected hamster and humans. Using a SOX9 antibody, we observed no persistent changes in astrocyte cell numbers in OB, ION, and hippocampus of infected hamsters compared to naïve animals ( Supplementary Fig. 5 ). In COVID-19 human tissue samples, GFAP + expression was increased in the medulla compared to controls ( Supplementary Fig. 6a) , and signi cant increases in IL-1β expression by GFAP + astrocytes were observed in the OB of COVID-19 patients when compared to controls. No differences in astrocytes were observed between COVID-19 and control patients in the hippocampus and medulla oblongata (Fig. 3h , Supplementary Fig. 6a ).

These data suggest that, while astrocytes may be involved in post-infection neuroin ammation in the OB, a region proximal to the location of viral replication, microglia and neurons appear to be the main players in more remote brain regions, like the medulla and hippocampus. Taken altogether, our ndings show that, despite lack of viral neuroinvasion, SARS-CoV-2-infected individuals develop microglial activation and cytokine expression in brain regions associated with olfactory function, motor coordination, memory and learning, possibly inducing neuropsychiatric signs and symptoms.

The formation and consolidation of new memories occurs primarily within the hippocampus and relies on the integrity of a trisynaptic circuit between the entorhinal cortex, dentate gyrus (DG), and Cornu Ammonis (CA) 29 . Spatial learning, in particular, relies on the link between synapses within the CA3 region and rates of adult neurogenesis, which occurs via generation of new neurons from neural progenitor cells 37 , as well as DCX + /Ki67 + cells, that were almost completely absent in the SGZ at 5 dpi (Fig. 4a,b) . Cell numbers normalized to pre-infection levels after day 5. There was no change in DCX + /Ki67 + cell numbers in the rostral migratory stream in infected hamster compared to uninfected controls ( Supplementary Fig. 7) . These data suggest that effects of neuroin ammation and IL-1β on neurogenesis are speci c to the DG.

To address the relevance of these ndings in humans, we compared numbers of DCX + neuroblast and DCX + /NeuN + immature neurons in the SGZ and granule cell layer (GCL) of a subset of COVID-19 decedents (n=8), and age-and sex-matched non-COVID-19 controls (n=8, Table 1 ). Adult hippocampal neurogenesis has been shown to persist into adulthood in healthy humans 38, 39 , with reports suggesting DCX + immature neurons are present into the ninth decade of life 40 . Because DCX + cells migrate from the SGZ into the GCL as they mature and start expressing NeuN 41 , DCX + /NeuNcells in the SGZ are more likely neuroblasts and DCX + /NeuN + cells located in the GCL are more likely immature neurons 42 . We quanti ed these populations separately in the SGZ and GCL (Supplementary Fig. 8) , and found fewer DCX + /NeuNneuroblasts in the SGZ of COVID-19 patients compared to non-COVID-19 controls (Fig. 4c,d) .

Conversely, DCX + /NeuNcells in the GCL and DCX + /NeuN + immature neurons in SGZ and GCL were not fewer in COVID-19 versus control subjects (Fig. 4c,d) . In mice neurogenesis takes approximately four weeks, and in monkeys it takes six months 43 , which is the time-frame these mammals carry their pregnancies. Thus, human neurogenesis might take nine months, and the more mature DCX + /NeuN + cells, and DCX + /NeuNthat have already migrated into the GCL, might have been generated weeks or months before the infection. On the other hand, cytokine surge and hypoxia appear to affect the more immature DCX + /NeuNcells located in the SGZ, possibly halting NPC differentiation into neuroblasts or reducing neuroblast survival. These hypotheses could be further tested in animal models where cell lineage can be traced, or in human brain via RNA velocity 44 .

We detected no signi cant effect of age on the number of DCX + /NeuN + and DCX + /NeuNcells in SGZ and GCL in COVID-19 patients or non-COVID-19 controls ( Supplementary Fig. 9 ), in line with previous ndings on the persistence of adult hippocampal neurogenesis in older subjects with no chronic neuropsychiatric illness [38] [39] [40] 45 .

Limitations of this study include the small sample sizes, and lack of reagents for detecting neural cell markers and additional in ammatory factors in hamsters. COVID-19 and non-COVID patients suffered hypoxia, which has been associated with activation of microglia in the absence of viral infection, and can also affect DCX + cells 26 . Although most of our controls did not have a history of intubation, given their medical history of cardiovascular disease and infections, they likely experienced elevated cytokines and hypoxic damage. Hamsters develop milder disease without hypoxia, which is different from humans who died from COVID-19. Since hamsters exhibited similar CNS damage as humans, brain alterations are most likely the result of in ammation associated with COVID-19.

This study identi es neurobiological mechanisms of CNS damage in SARS-CoV-2 infection. In hamster and humans, BBB disruption, cytokine expression, activated microglia and loss of hippocampal neurogenesis, may contribute to neuronal dysfunction/loss, and ultimately to neurocognitive or psychiatric symptoms. The absence of these brain changes in non-COVID patients deceased from other infections or cardiovascular disease suggests effects of neuroin ammation and hypoxia in COVID-19 patients may be speci c to SAR-CoV-2 infection.

Brain alterations were transient in hamsters, peaking after viral clearance in the nasal cavity. In humans, we do not know how long elevated in ammatory markers persist in subjects who survive the disease. The persistence of neuropsychiatric symptoms in long-COVID cases suggests that neuronal damage may be prolonged. Brain imaging studies investigating in ammation markers in post-COVID patient are warranted. Studies using positron emission tomography (PET) radiotracers for the brain translocator protein (TSPO) 46 located on microglia and astroglia, and transcranial near-infrared spectroscopy (NIRS) to assess mitochondrial function 47, 48 , may reveal useful for gathering data on indices of brain in ammation levels in post-COVID patients.

In hamsters and humans, BBB disruption and cytokine expression by microglia, astrocytes, and neurons occurred in a region-speci c fashion and were not associated with viral neuroinvasion 14 . Therefore, cytokines appear to be the main mediator of BBB disruption and cellular damage. NPC IL-1β receptors have been implicated in reducing neurogenesis in murine models of avivirus encephalitis 34, 50 . These viruses, however, lead to signi cant CNS in ltration of mononuclear cells, which has not been observed in studies of COVID-19.

Fewer DCX + neuroblasts in the SGZ of COVID-19 patients compared with non-COVID-19 controls suggests either decreased NPC maturation or increased neuroblast death. DCX expression has been hypothesized to occur in mature granule neurons that might be de-differentiating in pathological conditions 51 . However, this kind of cells would be more likely DCX + /NeuN + cell located in the GCL, which were unaffected. The time-course of human pathological ndings remains unknown, and if similar to hamsters, one would expect that after the initial cytokine surge, neurogenesis might recover, as cognitive symptoms and anosmia subside in many patients. Nevertheless, long-COVID symptoms have been widely reported 12 . There is the possibility that, in some individuals, the neurogenic niche might not have enough multipotent progenitors for neurogenesis to resume after this insult, as the multipotent progenitor pool of SOX2 + cells is smaller in aging humans 38 . If this was the case, some patients might not be able to recover, and COVID-19 may result in chronic neuropsychiatric symptoms, as observed in several clinical studies 2, 8, 13 .

Given the likely predominant role of neuroin ammation in the mechanism of brain damage in COVID-19, anti-IL-6 and anti-IL-1β therapies, currently under investigation 52 image of blood-brain permeability in the hamster brain 2 dpi, showing staining for IgG (green) and DAPI (blue), followed by quanti cation of IgG intensity in the CNS parenchyma (white outline). e.

Representative images of IgG detection (green) within hamster MO and hippocampi at naïve, 2, 3, 4, 5, 8, and 14 dpi, and nuclear stain, DAPI, (blue), followed by quanti cation of IgG intensity in their respective regions. f. Representative image of blood-brain permeability in the MO and hippocampus of control and COVID-19 patient tissue, depicting detection of brinogen (green) and DAPI (blue), followed by quanti cation of brinogen intensity. Data were pooled from at least two independent experiments. Scale bars, 50 μm (10x), 20 μm (20x) or 10 μm (63x). Data represent the mean ± s.e.m. and were analysed by two-way ANOVA or Student's t-test. presented as microscopy with IBA1 (red), IL-1β (green) and DAPI (blue) and percent IL-1β+ area and IL-

Central Nervous System Manifestations Associated with COVID-19

Frequency and pro le of objective cognitive de cits in hospitalized patients recovering from COVID-19

Short-term neuropsychiatric outcomes and quality of life in COVID-19 survivors

Post-acute COVID-19 syndrome

Pathogenesis and transmission of SARS-CoV-2 in golden hamsters

COVID-19: A Global Threat to the Nervous System

Global Incidence of Neurological Manifestations Among Patients Hospitalized With COVID-19-A Report for the GCS-NeuroCOVID Consortium and the ENERGY Consortium

Incidence, co-occurrence, and evolution of long-COVID features: A 6-month retrospective cohort study of 273,618 survivors of COVID-19

Neurologic Features in Severe SARS-CoV-2 Infection

Executive dysfunction in COVID-19 patients

COVID-19 pneumonia: relationship between in ammation assessed by whole-body FDG PET/CT and short-term clinical outcome

Cognitive pro le following COVID-19 infection: Clinical predictors leading to neuropsychological impairment

Long-term neuropsychiatric outcomes in COVID-19 survivors: A 1-year longitudinal study

COVID-19 neuropathology at Columbia University Irving Medical Center/New York Presbyterian Hospital

Neuropathological ndings from COVID-19 patients with neurological symptoms argue against a direct brain invasion of SARS-CoV-2: A critical systematic review

Neuropathology of patients with COVID-19 in Germany: a post-mortem case series

Cerebral Micro-Structural Changes in COVID-19 Patients -An MRI-based 3-month Follow-up Study

A single intranasal or intramuscular immunization with chimpanzee adenovirusvectored SARS-CoV-2 vaccine protects against pneumonia in hamsters

Massive transient damage of the olfactory epithelium associated with infection of sustentacular cells by SARS-CoV-2 in golden Syrian hamsters

Calcium store-mediated signaling in sustentacular cells of the mouse olfactory epithelium

Neurologic Alterations Due to Respiratory Virus Infections

Fibrinogen in neurological diseases: mechanisms, imaging and therapeutics

Blood-brain barrier breakdown, neuroin ammation, and cognitive decline in older adults

Active integration of glutamatergic input to the inferior olive generates bidirectional postsynaptic potentials

Increased CSF levels of IL-1beta, IL-6, and ACE in SARS-CoV-2-associated encephalitis

Mechanisms of microglial activation in models of in ammation and hypoxia: Implications for chronic intermittent hypoxia

Interleukin-6, a major cytokine in the central nervous system

The good, the bad, and the ugly of interleukin-6 signaling

Hippocampal function in rodents

Recruitment of adult-generated neurons into functional hippocampal networks contributes to updating and strengthening of spatial memory

Chronic peripheral in ammation, hippocampal neurogenesis, and behavior

Neuroprotection and neurogenesis: modulation of cornus ammonis 1 neuronal survival after transient forebrain ischemia by prior mbria-fornix deafferentation

Decreased adult neurogenesis in hibernating Syrian hamster

Astrocytes decrease adult neurogenesis during virus-induced memory dysfunction via IL-1

JAK2/STAT3 signaling mediates IL-6-inhibited neurogenesis of neural stem cells through DNA demethylation/methylation

Determination of key aspects of precursor cell proliferation, cell cycle length and kinetics in the adult mouse subgranular zone

Human Adult Neurogenesis: Evidence and Remaining Questions

Human Hippocampal Neurogenesis Persists throughout

Human Hippocampal Neurogenesis Persists in Aged Adults and Alzheimer's Disease Patients

Adult hippocampal neurogenesis is abundant in neurologically healthy subjects and drops sharply in patients with Alzheimer's disease

Intermediate progenitors support migration of neural stem cells into dentate gyrus outer neurogenic niches

Doublecortin is a microtubule-associated protein and is expressed widely by migrating neurons

Maturation time of new granule cells in the dentate gyrus of adult macaque monkeys exceeds six months

Generalizing RNA velocity to transient cell states through dynamical modeling

Considerations for Assessing the Extent of Hippocampal Neurogenesis in the Adult and Aging Human Brain

Neuroin ammation in psychiatric disorders: PET imaging and promising new targets

Cytochrome c oxidase dysfunction in oxidative stress

Exploring the Relevance of Senotherapeutics for the Current SARS-CoV-2 Emergency and Similar Future Global Health Threats

A role for interleukin-1beta in determining the lineage fate of embryonic rat hippocampal neural precursor cells

IL-1 reprogramming of adult neural stem cells limits neurocognitive recovery after viral encephalitis by maintaining a proin ammatory state

Expression of progenitor cell/immature neuron markers does not present de nitive evidence for adult neurogenesis

Clinical outcomes in COVID-19 patients treated with tocilizumab: An individual patient data systematic review

Representative image of IBA1 in control and COVID-19 patient ION, showing staining for IBA1 (magenta) and DAPI (blue) at 20x and 63x and quanti-ed for percent IBA1+ area. d, f Immunostaining for IL-1β and IBA1 in ION of control and COVID-19 patients, presented as microscopy with IBA1 (magenta), IL-1β (green) and DAPI (blue) and percent IL-1β+ area and IL-1β+IBA1+ area, normalized to total IBA1+ area. g. Im-munostaining for IL-6 and NeuN in ION of control and COVID-19 patients, presented as mi-croscopy with NeuN (red), IL-6 (green) and DAPI (blue) and percent IL-6+ area and IL-16+NeuN+ area, normalized to total NeuN+ area. Data were pooled from at least two independent experiments

DAPI (blue) at 20x and 63x and quanti ed for percent IBA1+ area. d, f Immunostaining for IL-1β and IBA1 in hippocampi of control and COVID-19 patients, presented as microscopy with IBA1 (magenta), IL-1β (green) and DAPI (blue) and percent IL-1β+ area and IL-1β+IBA1+ area, normalized to total IBA1+ ar-ea. g. Representative images of IBA1 in the human adult hippocampus with high magni cation images single channel. Sections stained with DAPI (blue), IBA1 (green), and DCX (red) in non-COVID-19 control. Scale bar, 25 μm

GFAP (green), and DCX (red) in non-COVID-19 control. The arrow points to a single DCX+/GFAP-neuron in the subgranular zone. Scale bar, 25 μm. i. Immunostaining for IL-6 and NeuN in hippocampi of control and COVID-19 patients, presented as microscopy with NeuN (red), IL-6 (green) and DAPI (blue) and percent IL-6+ area and IL-16+NeuN+ area

Data were pooled from at least two independent experiments. Scale bars, 20 μm (20x) or 10 μm (63x)

Data represent the mean ± s.e.m. and were ana-lysed by two-way ANOVA or Student's t-test

neuroblast (green), and DAPI (blue), followed by quanti cation of percent Ki67+DCX+ cells, normalized to the total number of DCX+ cells. c. Quanti cation of percent DCX+Ki67+ area, normalized to total DCX+ area in the rostral migra-tory stream of hamsters at naïve, 2, 3, 4, 5, 8, and 14 dpi. Data were pooled from at least two independent experiments. Scale bars, 50 μm. Data represent the mean ± s.e.m. and were analysed by twoway ANOVA. c. Select images of whole hippocampus & high magni cation images sections stained with DAPI (blue), NeuN (green), and DCX (red) from COVID-19 pa-tient and non-COVID-19 control. The granule cell layer (GCL), subgranular zone (SGZ), and molecular layer (ML) of the DG are visible, combined channels imaged at 20X; scale bar is 500 μm. High magni cation images were captured at 63x, scale bar is 20 μm. d. In the SGZ, DCX+/NeuN-cells were fewer in COVID-19 patients vs controls (p = 0.026; t(7.794) = 2.731; Welch's t test for non-stoichiometric data), with no group differences in DCX+/NeuN+ cell number (p = 0.189; Mann-Whitney)

The authors thank W. Beatty at the Molecular Microbiology Imaging facility at Washington University School of Medicine and the teams at the New York State Psychiatric Institute for performing psychological autopsy interviews. We dedicate this study to the donors and their families, who contributed to this scienti c inquiry despite the extraordinary strain they suffered at the beginning of the pandemic.